CytoMed Therapeutics Limited share price logo

CytoMed Therapeutics Limited

NASDAQ: GDTC

$0.92

as on

CytoMed Therapeutics Limited Stock Performance

as on October 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.90
    $0.92
    downward going graph

    2.07%

    Downside

    0.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.68
    $3.10
    downward going graph

    26.00%

    Downside

    237.32%

    Upside

    downward going graph

CytoMed Therapeutics Limited share price movements today

Previous Close
$0.92
Open
$0.91
Volume
55.4K
Market Cap
$11.0M
Day's Low - High
$0.90 - $0.92
52 Week Low - High
$0.68 - $3.10

CytoMed Therapeutics Limited Historical Returns

1 Month Return
-3.77 %
3 Month Return
-7.17 %
1 Year Return
-61.55 %
3 Year Return
-73.82 %
5 Year Return
0 %

CytoMed Therapeutics Limited Stock Fundamentals & Key Indicators

Check CytoMed Therapeutics Limited market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$11.0M

EPS (TTM)

-0.4384

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.68

Industry PE ratio

-4.15

PEG Ratio

0.17

EBITDA

-4.8M

Revenue (TTM)

720.3K

Profit Margin

-577.72%

Return On Equity TTM

-91.37%

CytoMed Therapeutics Limited vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CytoMed Therapeutics Limited with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
CytoMed Therapeutics Limited image
CytoMed Therapeutics Limited
Buy$11.0MNA-2.68-577.72%0.00%
Moderna image
Moderna
Neutral$79.9B-42.12%-25.08-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.8B184.64%30.2586.04%0.00%
Regeneron image
Regeneron
Buy$82.9B35.95%19.2284.86%0.46%

Stock Returns calculator for CytoMed Therapeutics Limited Stock including INR - Dollar returns

The CytoMed Therapeutics Limited stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

CytoMed Therapeutics Limited investment value today

Current value as on today

₹41,379

Returns

-₹58,621

(-58.62%)

Returns from CytoMed Therapeutics Limited Stock

-₹61,548 (-61.55%)

Dollar Impact

₹2,927 (+2.93%)

Analyst Recommendation on CytoMed Therapeutics Limited Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for CytoMed Therapeutics Limited. Average target price of $4.16

CytoMed Therapeutics Limited Share Price Target

Get share price movements and forecasts by analysts on CytoMed Therapeutics Limited.

What analysts predicted

77.91%UPSIDE

Target Price

$4.16

Current Price

$0.919

Analyzed by

1 Analysts

High

$4.16

Target

$4.16

Low

$4.16

CytoMed Therapeutics Limited target price $4.16, a slight upside of 77.91% compared to current price of $0.919. According to 1 analysts rating.

Indian Investors' Interest in CytoMed Therapeutics Limited Stock

Search interest for CytoMed Therapeutics Limited Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-60% versus previous 30 day period

CytoMed Therapeutics Limited Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
-1
0
-2
0
-2
0
-2
Operating Income
0
0
0
-1
0
-2
0
-2
0
-2
EBITDA
0
0
0
-1
-1
-2
0
-1
0
-1
Interest Expense
-
-
-
0
0
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
-1
-1
-2
0
-1
0
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
0
-1
-1
-2
0
-1
0
-1
Net Profit Margin
98.94%
99.01%
89.67%
174.87%
93.07%
-1499.71%
84.40%
-1454.73%
87.51%
-1302.69%

CytoMed Therapeutics Limited Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
0
Gross Profit
-
0
0
-
-4
0
0
Operating Income
0
-1
-1
-2
-4
-3
-4
EBITDA
0
-1
-1
-2
-3
-2
-3
Interest Expense
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-1
-2
-3
-4
-2
-3
Income Tax Expense
-
-
-
0
0
-
-
Net Income
0
-1
-2
-3
-4
-2
-3
Net Profit Margin
0.00%
92.22%
96.92%
0.00%
131.44%
75.37%
79.04%

CytoMed Therapeutics Limited Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Mar 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
0
0
-1
-2
0
-1
0
-1
Operating Cash Flow
0
0
0
0
0
-1
-1
-2
0
-1
Investing Cash Flow
1
0
1
2
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
0
Change in Cash
-5
-1
0
0
0
-1
-
0
-
0

CytoMed Therapeutics Limited Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
0
-1
-2
-3
-4
-2
-3
Operating Cash Flow
0
0
-1
-1
-3
-2
-3
Investing Cash Flow
-1
0
0
0
-2
1
0
Financing Cash Flow
1
1
4
0
10
0
0
Change in Cash
0
0
1
0
4
-1
-2

Global Institutional Holdings in CytoMed Therapeutics Limited

Check out the Institutions with significant holdings in CytoMed Therapeutics Limited.

Funds
Holdings
Fidelity Concord Street Trust
0.04%

Insights on CytoMed Therapeutics Limited

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, GDTC stock has moved up by 7.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 648.3% return, outperforming this stock by 709.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 163.4% return, outperforming this stock by 237.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -885.22K → -1.77M (in $), with an average decrease of 100.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 189.44K → 157.28K (in $), with an average decrease of 17.0% per quarter

About CytoMed Therapeutics Limited

CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
OrganisationCytoMed Therapeutics Limited
Headquarters1 Commonwealth Lane, No. 08-22, Singapore, CE, 149544, SG
IndustryBiotechnology
CEOChee Kong Choo

Key Management of CytoMed Therapeutics Limited

Name

Title

Ms. Yoong Ying Tan

Chief Corporate Officer

Mr. Chee Kong Choo

Executive Chairman

Dr. Jieming Zeng M.D., Ph.D.

Chief Scientific & Medical Officer and Director

Ms. Yvonne Goh

Chief Financial Officer

Dr. Tien Wee Luk M.D.

Chief Clinical Officer

FAQs

What is CytoMed Therapeutics Limited share price today?

CytoMed Therapeutics Limited share price today is $0.92 as on at the close of the market. CytoMed Therapeutics Limited share today touched a day high of $0.92 and a low of $0.90.

What is the 52 week high and 52 week low for CytoMed Therapeutics Limited share?

CytoMed Therapeutics Limited share touched a 52 week high of $3.10 on and a 52 week low of $0.68 on . CytoMed Therapeutics Limited stock price today i.e. is closed at $0.92,which is 70.35% down from its 52 week high and 35.13% up from its 52 week low.

What is CytoMed Therapeutics Limited's market capitalisation today?

CytoMed Therapeutics Limited market capitalisation is $0.00T as on .

How to invest in CytoMed Therapeutics Limited Stock (GDTC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CytoMed Therapeutics Limited on INDmoney app. Click on Buy button.

What is the minimum amount required to buy CytoMed Therapeutics Limited Stock (GDTC) from India?

Indian investors can start investing in CytoMed Therapeutics Limited (GDTC) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in CytoMed Therapeutics Limited stock (as per the Rupee-Dollar exchange rate as on ). Based on CytoMed Therapeutics Limited share’s latest price of $0.92 as on October 26, 2026 at 8:46 am IST, you will get 10.8814 shares of CytoMed Therapeutics Limited. Learn more about fractional shares .